This report was first published by Endpoints News. To see the original version, click here
BERLIN — At Europe’s largest cancer conference, Sunday’s main stage belonged to China.
Medical conferences use their keynote sessions to highlight results from what the top researchers in the world think are the most important trials in their field. And at the European Society for Medical Oncology’s annual meeting, three of the four presentations during Sunday’s presidential symposium were for studies conducted in China, by Chinese companies.
您已閱讀15%（535字），剩余85%（3026字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。